Carbinoxamine tannate 3.6 mg / dextromethorphan tannate 27.5 mg / pseudoephedrine tannate 45.2 mg in 5 mL Extended Release Suspension
RxNorm 1012974
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012974 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine tannate 3.6 mg / dextromethorphan tannate 27.5 mg / pseudoephedrine tannate 45.2 mg in 5 mL Extended Release Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine tannate 0.72 mg/ML / dextromethorphan tannate 5.5 mg/ML / pseudoephedrine tannate 9.04 mg/ML Extended Release Suspension
(Atom ID: 12329106)
PSN
Prescribable Name (PSN):
Carbinoxamine tannate 3.6 mg / dextromethorphan tannate 27.5 mg / pseudoephedrine tannate 45.2 mg in 5 mL Extended Release Suspension
(Atom ID: 13050078)
SY